SwePub
Sök i LIBRIS databas

  Extended search

onr:"swepub:oai:lup.lub.lu.se:2ad795de-7fba-4dfe-8463-7a9c811af836"
 

Search: onr:"swepub:oai:lup.lub.lu.se:2ad795de-7fba-4dfe-8463-7a9c811af836" > Preoperative and pe...

  • 1 of 1
  • Previous record
  • Next record
  •    To hitlist

Preoperative and perioperative use of levosimendan in cardiac surgery: European expert opinion.

Toller, W (author)
Heringlake, M (author)
Guarracino, F (author)
show more...
Algotsson, Lars (author)
Lund University,Lunds universitet,Anestesiologi och intensivvård,Sektion II,Institutionen för kliniska vetenskaper, Lund,Medicinska fakulteten,Anesthesiology and Intensive Care,Section II,Department of Clinical Sciences, Lund,Faculty of Medicine
Alvarez, J (author)
Argyriadou, H (author)
Ben-Gal, T (author)
Černý, V (author)
Cholley, B (author)
Eremenko, A (author)
Guerrero-Orriach, J L (author)
Järvelä, K (author)
Karanovic, N (author)
Kivikko, M (author)
Lahtinen, P (author)
Lomivorotov, V (author)
Mehta, R H (author)
Mušič, Š (author)
Pollesello, P (author)
Rex, S (author)
Riha, H (author)
Rudiger, A (author)
Salmenperä, M (author)
Szudi, L (author)
Tritapepe, L (author)
Wyncoll, D (author)
Öwall, A (author)
Karolinska Institutet
show less...
 (creator_code:org_t)
Elsevier BV, 2015
2015
English.
In: International Journal of Cardiology. - : Elsevier BV. - 0167-5273 .- 1874-1754. ; 184, s. 323-336
  • Research review (peer-reviewed)
Abstract Subject headings
Close  
  • In cardiac surgery, postoperative low cardiac output has been shown to correlate with increased rates of organ failure and mortality. Catecholamines have been the standard therapy for many years, although they carry substantial risk for adverse cardiac and systemic effects, and have been reported to be associated with increased mortality. On the other hand, the calcium sensitiser and potassium channel opener levosimendan has been shown to improve cardiac function with no imbalance in oxygen consumption, and to have protective effects in other organs. Numerous clinical trials have indicated favourable cardiac and non-cardiac effects of preoperative and perioperative administration of levosimendan. A panel of 27 experts from 18 countries has now reviewed the literature on the use of levosimendan in on-pump and off-pump coronary artery bypass grafting and in heart valve surgery. This panel discussed the published evidence in these various settings, and agreed to vote on a set of questions related to the cardioprotective effects of levosimendan when administered preoperatively, with the purpose of reaching a consensus on which patients could benefit from the preoperative use of levosimendan and in which kind of procedures, and at which doses and timing should levosimendan be administered. Here, we present a systematic review of the literature to report on the completed and ongoing studies on levosimendan, including the newly commenced LEVO-CTS phase III study (NCT02025621), and on the consensus reached on the recommendations proposed for the use of preoperative levosimendan.

Subject headings

MEDICIN OCH HÄLSOVETENSKAP  -- Klinisk medicin -- Kardiologi (hsv//swe)
MEDICAL AND HEALTH SCIENCES  -- Clinical Medicine -- Cardiac and Cardiovascular Systems (hsv//eng)

Publication and Content Type

for (subject category)
ref (subject category)

Find in a library

To the university's database

  • 1 of 1
  • Previous record
  • Next record
  •    To hitlist

Kungliga biblioteket hanterar dina personuppgifter i enlighet med EU:s dataskyddsförordning (2018), GDPR. Läs mer om hur det funkar här.
Så här hanterar KB dina uppgifter vid användning av denna tjänst.

 
pil uppåt Close

Copy and save the link in order to return to this view